Filing Details

Accession Number:
0000950170-23-010969
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-30 16:26:36
Reporting Period:
2022-03-30
Accepted Time:
2023-03-30 16:26:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1785173 89Bio Inc. ETNB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1352908 R Michael Hayden C/O 89Bio, Inc.
142 Sansome Street, 2Nd Floor
San Francisco CA 94104
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-03-30 6,250 $3.62 83,978 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-04-07 10,000 $3.48 93,978 No 4 P Indirect See footnote
Common Stock Acquisiton 2022-04-25 10,000 $2.67 103,978 No 4 P Indirect See footnote
Common Stock Acquisiton 2023-03-28 61,538 $16.15 61,538 No 4 P Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
No 4 P Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 80,904 Direct
Footnotes
  1. These shares are held directly by Genworks 2 Consulting Inc., over which the Reporting Person's wife has sole voting and investment power.
  2. This transaction was executed in multiple trades at prices ranging from $2.6499 to $2.699. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. These shares are held directly by The Hayden Family Trust, over which the Reporting Person's wife has sole voting and investment power.